PTPRC and neoplasm: The quality of the CD45+ immune tumor infiltrate also selectively changed with an increase in the percentage of CD3+CD8+ T cells recruited at the tumor site, indicating that B16 reactive CD8+ T cells were trafficking to tumor in vivo (Figure 3B-D).